Enhanced Computed Tomography Radiomics Predicts Solute Carrier Family 7, Member 11 in Head and Neck Squamous Cell Carcinoma

Overview

Journal Front Genet

Date 2024 Oct 1

PMID 39350768

Authors

Jilian Lv

Xiangze Meng

Yuanyuan Li

Rui Zhang

Yuan Zhao

Xi Yang

Fang Wang

Xinbin Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: Traditional prognostic indicators for head and neck squamous cell carcinoma (HNSCC), such as clinicopathological features, human papillomavirus status, and imaging examinations, often lack precision in guiding medical therapy. Therefore, discovering novel tumor biomarkers that can accurately assess prognosis and aid in personalized medical treatment for HNSCC is critical. Solute carrier family 7, member 11 (SLC7A11), is implicated in ferroptosis, and various malignant tumor therapies regulate its expression. However, the mechanisms regulating SLC7A11 expression, the transporter activity, and its specific role in controlling ferroptosis in cancer cells remain unknown. Thus, in this study, we aimed to develop an improved computed tomography (CT) radiomics model that could predict SLC7A11 expression in patients with HNSCC.

Methods: We used patient genomic data and corresponding augmented CT images for prognostic analysis and building models. Further, we investigated the potential molecular mechanisms underlying SLC7A11 expression in the immune microenvironment. Our radiomics model successfully predicted mRNA expression in HNSCC tissues and elucidated its association with relevant genes and prognostic outcomes.

Results: SLC7A11 expression level was high within tumor tissues and was connected to the infiltration of eosinophil, CD8 T-cell, and macrophages, which was associated with poor overall survival. Our models demonstrated robust predictive power. The distribution of radiomics scores (RAD scores) within the training and validation sets was markedly different between the high- and low-expression groups of SLC7A11.

Conclusion: SLC7A11 is likely an important factor in the prognosis of HNSCC. SLC7A11 expression can be predicted effectively and reliably by radiomics models based on enhanced CT.

References

Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

Cramer J, Burtness B, Le Q, Ferris R . The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019; 16(11):669-683. DOI: 10.1038/s41571-019-0227-z. View

Leemans C, Snijders P, Brakenhoff R . The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018; 18(5):269-282. DOI: 10.1038/nrc.2018.11. View

Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View

Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T . Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis. Curr Top Microbiol Immunol. 2017; 403:143-170. DOI: 10.1007/82_2016_508. View

Sun R, Limkin E, Vakalopoulou M, Dercle L, Champiat S, Han S . A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018; 19(9):1180-1191. DOI: 10.1016/S1470-2045(18)30413-3. View

Feng L, Zhao K, Sun L, Yin X, Zhang J, Liu C . SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 2021; 19(1):367. PMC: 8393811. DOI: 10.1186/s12967-021-03042-7. View

Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X . Ferroptosis: process and function. Cell Death Differ. 2016; 23(3):369-79. PMC: 5072448. DOI: 10.1038/cdd.2015.158. View

Lang X, Green M, Wang W, Yu J, Choi J, Jiang L . Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019; 9(12):1673-1685. PMC: 6891128. DOI: 10.1158/2159-8290.CD-19-0338. View

10.

Liu X, Olszewski K, Zhang Y, Lim E, Shi J, Zhang X . Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020; 22(4):476-486. PMC: 7194135. DOI: 10.1038/s41556-020-0496-x. View

11.

Koppula P, Zhuang L, Gan B . Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2020; 12(8):599-620. PMC: 8310547. DOI: 10.1007/s13238-020-00789-5. View

12.

Bieging K, Mello S, Attardi L . Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014; 14(5):359-70. PMC: 4049238. DOI: 10.1038/nrc3711. View

13.

Cao J, Dixon S . Mechanisms of ferroptosis. Cell Mol Life Sci. 2016; 73(11-12):2195-209. PMC: 4887533. DOI: 10.1007/s00018-016-2194-1. View

14.

Li D, Li Y . The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 2020; 5(1):108. PMC: 7327075. DOI: 10.1038/s41392-020-00216-5. View

15.

Koppula P, Zhang Y, Shi J, Li W, Gan B . The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. J Biol Chem. 2017; 292(34):14240-14249. PMC: 5572906. DOI: 10.1074/jbc.M117.798405. View

16.

Kaleeba J, Berger E . Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science. 2006; 311(5769):1921-4. DOI: 10.1126/science.1120878. View

17.

Tang D, Kang R, Vanden Berghe T, Vandenabeele P, Kroemer G . The molecular machinery of regulated cell death. Cell Res. 2019; 29(5):347-364. PMC: 6796845. DOI: 10.1038/s41422-019-0164-5. View

18.

Peng Z, Wang Y, Wang Y, Jiang S, Fan R, Zhang H . Application of radiomics and machine learning in head and neck cancers. Int J Biol Sci. 2021; 17(2):475-486. PMC: 7893590. DOI: 10.7150/ijbs.55716. View

19.

Lin W, Wang C, Liu G, Bi C, Wang X, Zhou Q . SLC7A11/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020; 10(10):3106-3126. PMC: 7642655. View

20.

Yang W, Sriramaratnam R, Welsch M, Shimada K, Skouta R, Viswanathan V . Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1-2):317-331. PMC: 4076414. DOI: 10.1016/j.cell.2013.12.010. View